Robin Foà, ASH 2021: Measurable Residual Disease in the Management of Haematological Malignancies (PART TWO)
We were delighted to catch up with touchONCOLOGY editorial board member Professor Robin Foà (Sapienza University of Rome, Italy) to discuss his educational session at the 63rd ASH Annual Meeting & Exposition on measurable residual disease in the management of many haematological malignancies. (PART TWO)
Questions
1. Could you give us a brief overview of the concept of measurable residual disease (MRD) and how its use has evolved? 00:17-03:18
2. How is MRD assessed? 03:18-05:55
Speaker Disclosure: Robin Foà has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the 63rd ASH Annual Meeting & Exposition